2552-45-6 Usage
Description
METHYL 4-CHLORO-3,5-DINITROBENZOATE, with the molecular formula C8H6ClNO5, is a yellow, crystalline solid that is insoluble in water but soluble in organic solvents. It is a chemical compound often utilized as a precursor in the synthesis of other organic compounds.
Uses
Used in Chemical Synthesis:
METHYL 4-CHLORO-3,5-DINITROBENZOATE is used as a precursor for the synthesis of other organic compounds, playing a crucial role in the creation of various chemical products.
Used in Dye Manufacturing:
In the dye industry, METHYL 4-CHLORO-3,5-DINITROBENZOATE is used as a key component in the manufacturing process, contributing to the development of different types of dyes.
Used in Pharmaceutical Production:
METHYL 4-CHLORO-3,5-DINITROBENZOATE is also utilized in the pharmaceutical sector, where it serves as a vital ingredient in the production of certain drugs.
Safety Note:
METHYL 4-CHLORO-3,5-DINITROBENZOATE is a hazardous chemical, and it is essential to handle it with care and in accordance with proper safety protocols to ensure the safety of individuals and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 2552-45-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,5,5 and 2 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 2552-45:
(6*2)+(5*5)+(4*5)+(3*2)+(2*4)+(1*5)=76
76 % 10 = 6
So 2552-45-6 is a valid CAS Registry Number.
InChI:InChI=1/C8H5ClN2O6/c1-17-8(12)4-2-5(10(13)14)7(9)6(3-4)11(15)16/h2-3H,1H3
2552-45-6Relevant articles and documents
HIGHLY ACTIVE STING PROTEIN AGONIST COMPOUND
-
Paragraph 0410-0412, (2021/07/17)
The present invention provides compounds of Formula (I) or (II), pharmaceutical compositions thereof, and methods of using compounds of Formula (I) or (II) to prevent and/or treat immune-related disorders.
DENDRITIC COMPOUNDS INCLUDING A CHELATING, FLUOROCHROME OR RECOGNITION AGENT, COMPOSITIONS INCLUDING SAME AND USES THEREOF
-
Paragraph 0350; 0351; 0352, (2016/08/29)
The invention relates to dendritic compounds comprising a chelating, fluorochrome or recognition agent of formula (I), to compositions comprising same, and to uses thereof, wherein in said formula (I): T, L1, D, R, L2, V and n are as defined in the description.
Second generation of BACE-1 inhibitors part 2: Optimisation of the non-prime side substituent
Charrier, Nicolas,Clarke, Brian,Demont, Emmanuel,Dingwall, Colin,Dunsdon, Rachel,Hawkins, Julie,Hubbard, Julia,Hussain, Ishrut,Maile, Graham,Matico, Rosalie,Mosley, Julie,Naylor, Alan,O'Brien, Alistair,Redshaw, Sally,Rowland, Paul,Soleil, Virginie,Smith, Kathrine J.,Sweitzer, Sharon,Theobald, Pam,Vesey, David,Walter, Daryl S.,Wayne, Gareth
scheme or table, p. 3669 - 3673 (2010/03/24)
Our first generation of hydroxyethylamine transition-state mimetic BACE-1 inhibitors allowed us to validate BACE-1 as a key target for Alzheimer's disease by demonstrating amyloid lowering in an animal model, albeit at rather high doses. Finding a molecul
